title: Acute-phase reactants and cytokines in ischemic stroke: do they have any relationship with short-term mortality?
abstract: BACKGROUND
  Many unknown risk factors play a role in the etiopathogenesis of stroke. The appearance of inflammatory cells within the damaged tissue after cerebral ischemia suggests that an inflammatory response may play a role in stroke pathogenesis. In our study, we examined whether an association exists between the acute-phase reactants and the levels of cytokines, the volume and diameter of the stroke, and short-term mortality in patients who were diagnosed as acute ischemic a stroke after admission to the Emergency Department.
  
  
  METHODS
  A total of 50 consecutive patients who applied to the Emergency Service with acute ischemic stroke were enrolled in the study. Their stroke volume were calculated and serum samples were obtained as soon as they arrived into the Emergency Service. The patients were evaluated according to the Glasgow Coma Scale (GCS) and National Institutes of Health Stroke Scale (NIHSS).
  
  
  RESULTS
  There was no significant correlations between stroke volume and levels of cytokine and acute-phase reactants in dead patient group or in living patient group. A correlation and statistical significance was found between stroke volume and hospital stay time in living patient group. In addition, GCS and NIHSS scores were correlated with stroke volume and was found a significant statistically.
  
  
  CONCLUSIONS
  Scales such as GKS and NIHHS, which evaluate the functional state of patients, are the best indicators for defining prognosis in our daily practices. In addition, we found a positive correlation between levels of CRP (C reactive protein) and prognosis. However, we did not observe a statistically significant correlation between prognosis and other acute-phase reactants such as TNF-alpha, IL-6, IL-8, IL-10, fibrinogen, and leukocytes.
authors.affiliation: Emergency Medicine Service, Elazıg Education and Research Hospital, Elazig, Turkey. salim.satar@yahoo.com.
authors.forename: M
authors.initials: M
authors.lastname: Sahan
authors.forename: A
authors.initials: A
authors.lastname: Sebe
authors.forename: A
authors.initials: A
authors.lastname: Acikalin
authors.forename: O
authors.initials: O
authors.lastname: Akpinar
authors.forename: F
authors.initials: F
authors.lastname: Koc
authors.forename: M O
authors.initials: MO
authors.lastname: Ay
authors.forename: M
authors.initials: M
authors.lastname: Gulen
authors.forename: M
authors.initials: M
authors.lastname: Topal
authors.forename: S
authors.initials: S
authors.lastname: Satar
mesh_terms: D000328:Adult; D000368:Aged; D002545:Brain Ischemia / Q000097:blood / Q000209:etiology / Q000401:mortality*; D002097:C-Reactive Protein / Q000032:analysis*; D016207:Cytokines / Q000097:blood*; D005260:Female; D015600:Glasgow Coma Scale; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors; D020521:Stroke / Q000097:blood / Q000209:etiology / Q000401:mortality*
chemical_list: D016207:Cytokines; D002097:C-Reactive Protein